| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 38.366 | 50.971 | 43.700 | 66.311 | 61.908 |
| Total Income - EUR | - | - | - | - | - | 38.366 | 50.971 | 43.700 | 66.311 | 61.908 |
| Total Expenses - EUR | - | - | - | - | - | 8.428 | 21.816 | 18.397 | 32.330 | 36.598 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 29.937 | 29.155 | 25.302 | 33.981 | 25.310 |
| Net Profit/Loss - EUR | - | - | - | - | - | 28.846 | 27.626 | 24.235 | 33.318 | 23.676 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Urologie-Andrologie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 2 | 0 | 887 | 2.648 | 0 |
| Current Assets | - | - | - | - | - | 29.449 | 28.143 | 24.430 | 39.501 | 65.365 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 521 | 518 |
| Receivables | - | - | - | - | - | 28.770 | 20.771 | 22.820 | 30.759 | 54.265 |
| Cash | - | - | - | - | - | 679 | 7.372 | 1.610 | 8.222 | 10.582 |
| Shareholders Funds | - | - | - | - | - | 28.887 | 27.674 | 24.284 | 37.871 | 61.335 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 564 | 469 | 1.033 | 4.278 | 4.473 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Urologie-Andrologie S.r.l.